Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA
NCT07418125 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130
Last updated 2026-02-18
Summary
CTCs, CTC clusters, and ctDNA may predict treatment response and survival in high-risk breast cancer, including IBC.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Liquid biopsy
Additional liquid biopsy to monitor disease
Sponsors & Collaborators
-
Institute of Oncology Ljubljana
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-02-07
- Primary Completion
- 2028-12-31
- Completion
- 2028-12-31
Countries
- Slovenia
Study Locations
More Related Trials
-
Identification of Novel Genetic Factors That Contribute to Risk for Breast Cancer
NCT00276120 ·Status: COMPLETED
-
Investigation of Novel Surgical Imaging for Tumor Excision
NCT03686215 ·Status: COMPLETED ·Phase: PHASE3
-
Precision Retrospective Integrative Study for Metastatic Lymph Nodes in Breast Cancer
NCT06738459 ·Status: RECRUITING
-
Axillary Lymph Node Status After Completion of Preoperative Neoadjuvant Systemic Chemotherapy in Patients
NCT00507611 ·Status: COMPLETED ·Phase: NA
-
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC
NCT04480814 ·Status: COMPLETED
-
Breast Cancer Detection in Breast Surgical Specimens With the Histolog Scanner, Slide-free Confocal Microscope
NCT04976556 ·Status: COMPLETED
-
Breast Cancer Liquid Biopsy Stratification
NCT03992521 ·Status: UNKNOWN
-
Feasibility Study of Intraoperative Imaging in Breast Cancer
NCT02438358 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Detecting Circulating Tumor Cells (CTCs) and Cell Free DNA (cfDNA) in Peripheral Blood of Breast Cancer (BC) Patients to Develop the Clinical Application for Early Detection and Diagnostics
NCT03511859 ·Status: UNKNOWN
-
Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device
NCT06807502 ·Status: RECRUITING ·Phase: NA
-
Additional Imaging Methods for Assessing Axillary Lymph Node Involvement in Breast Cancer
NCT07418411 ·Status: COMPLETED ·Phase: NA
-
Sentinel Lymph Node Total Tumoral Load as a Predictor of Non Sentinel Node Involvement in Early Breast Cancer
NCT01669265 ·Status: COMPLETED
-
Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer
NCT06418126 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer
NCT07070128 ·Status: RECRUITING
-
Understanding CARdiac Events in Breast Cancer
NCT05921279 ·Status: RECRUITING
-
Study of Sentinel Lymph Node Assessment Following Previous Surgical Biopsy for Early Breast Cancer
NCT00293865 ·Status: COMPLETED ·Phase: NA
-
Sentinel Lymph Node Biopsy in Patients With Breast Cancer After Neoadjuvant Therapy
NCT03556397 ·Status: COMPLETED ·Phase: NA
-
Genomic Signatures to Predict Treatment Response
NCT02032745 ·Status: COMPLETED
-
Pilot Clinical Study on a Low-power Electromagnetic Wave Breast Imaging Device for Cancer Screening Purposes.
NCT03475992 ·Status: COMPLETED ·Phase: NA
-
Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer
NCT02481128 ·Status: COMPLETED ·Phase: NA
-
BC-DAISY: A Breast Cancer Decision Aid System
NCT00347568 ·Status: COMPLETED ·Phase: NA
-
TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence
NCT04874064 ·Status: RECRUITING
-
Identification of New Prognostic Markers for Breast Cancer.
NCT03436069 ·Status: RECRUITING
-
A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer
NCT02761616 ·Status: COMPLETED
-
High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
NCT00291096 ·Status: RECRUITING